-
May, 21 2023 — The May 2023
Medicare Part D formulary updates included
49 new drug codes or NDCs representing 32 different medications.
The NDC uniquely identifies a particular manufacturer, drug-strength,
and . . .
-
May, 21 2023 — The May 2023 Medicare Part D plan drug list updates include two newly-introduced generics: BISOPROLOL-HCTZ [Ziac] and LEVOFLOXACIN DROPS. The updates include the addition of 49 new National Drug Codes (NDCs), representing 32 different prescription drugs.
-
Apr, 30 2023 — The April 2023 Medicare Part D plan drug list updates include six newly-introduced generics: BRIMONIDINE [Mirvaso®] DICLOFENAC POTASSIUM [Cambia®] SODIUM OXYBATE [Xyrem®] TOPIRAMATE ER [Trokendi XR® Qudexy XR®] and seven newly-introduced brand-name drugs: AMJEVITA® . . .
-
Mar, 25 2023 — Can my Medicare drug plan drop the coverage of one of my prescriptions during the plan year? Yes. Your 2023 Medicare Part D prescription drug plan's formulary or drug list can change throughout the year adding new generic or brand-name drugs - or removing drugs.
-
Mar, 25 2023 — The March 2023 Medicare Part D plan drug list updates include two newly-introduced generics: ESTRADIOL [Divigel®] and METRONIDAZOLE [Vandazole®] and three newly-introduced brand-name drugs: AUVELITY®, ROXYBOND®, and ZORYVE®
-
Feb, 28 2023 — As you may know, Medicare Part D prescription drug plans update their plan formularies (drug lists) throughout the plan year and the February 2023
Medicare Part D formulary updates included Seventy-o . . .
-
Feb, 28 2023 — The February 2023 Medicare Part D plan drug list updates include 16 newly-introduced generics and 16 newly-introduced brand drugs, including: ADLARITY®, CAPLYTA®, CRESEMBA®, DESCOVY®, ENTADFI®, HYFTOR®, JYNNEOS®, OSMOLEX ER®, PHEBURANE®, RELEUKO®, RELYVRIO®, and others
-
Aug, 13 2022 — The August 2022
Medicare Part D plan formulary (or drug list) updates included
39 new drug codes or NDCs representing
33 different medications.
The NDC uniquely identifies a particular manufactu . . .
-
Aug, 13 2022 — The August 2022 Medicare Part D plan drug list updates include two (2) newly-introduced
generics and six (6) newly-introduced brand drugs, including: CYSTARAN®,
PREHEVBRIO®, REVCOVI®, SEGLENTIS®, TWYNEO®, and ZIMHI®.
-
Jun, 17 2022 — The June 2022 Medicare Part D plan drug list updates include ten (10) newly-introduced
generics and seven (7) newly-introduced brand drugs, including: FLEQSUVY®,
IBSRELA®, LOFENA®, PHEXXI®, PYRUKYND®, SOAANZ®, and ZEGALOGUE®.
-
May, 19 2022 — The May 2022 Medicare Part D plan drug list updates include six (6) newly-introduced generics and five (5) newly-introduced brand drugs, including: CIBINQO®, DARTISLA®, DHIVY®, ELYXYB®, and RECORLEV®.
-
Apr, 19 2022 — The April 2022 Medicare Part D plan drug list updates include five (5) newly-introduced generics and six (6) newly-introduced brand drugs, including: ADBRY®, BYLVAY®, CORTROPHIN®, SKYTROFA®, TARPEYO®, and VOXZOGO®.
-
Mar, 29 2022 — The March 2022 Medicare Part D plan drug list updates include 3 newly-introduced generics and 12 newly-introduced brand drugs, including: BESREMI®, CENTANY®, EPRONTIA®, EXKIVITY®, LIVMARLI®, LIVTENCITY®, OPZELURA®, QULIPTA®, SCEMBLIX®, TICOVAC®, TRUDHESA®, VUITY®
-
Feb, 28 2022 — The February 2022 Medicare Part D plan drug list updates include eight (8) newly-introduced generic drugs - and nine (9) newly-introduced brand-name drugs, including: INVEGA HAFYERA®, LOREEV XR®, LYBALVI®, PENTACEL®, TAVNEOS®, TRUSELTIQ®, TYRVAYA®, WELIREG®, and WINLEVI®
-
Aug, 14 2021 — The August 2021 Medicare Part D plan formulary (or drug list) updates included 39 new drug codes or NDCs representing 25 different medications, including 14 new generics.
The NDC uniquely identifie . . .